Title : An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease - Kainuma_2022_Front.Pharmacol_13_991982
Title : Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan - Ueda_2019_Dement.Geriatr.Cogn.Dis.Extra_9_302